Your Antibodies for Therapy
Providing the antibodies to meet
your target validation assays

MAbQi delivers readily developable human antibodies for your pipeline


Recognized team
of experts in antibody discovery

Proprietary in vitro
optimized human library

100% delivery
track records of today*
(*) > 30 (academic) programs including: GPCR agonists, enzyme inhibitors, anti-splicing-variants, anti-post-translational modifications, anti-receptor tyrosine kinases, anti-ligand, … (many of them cross-reactive human/mouse)

TECHNOLOGY
- Proprietary synthetic Ab library
- In vitro screening methods validated on :
- - integral membrane proteins
- - soluble proteins
- - peptides
ABOUT US
Mabqi, founded upon best
in class technology from Inserm,
is a biotech company with an integrated
approach to develop human antibodies.

LATEST NEWS
Mabqi will be attending at the Convention BIO US
Mabqi will be attending at the Convention BIO US from the 5th to the 8th June at Boston, USA.Get all the information and register at https://www.bio.org/events/bio-international-convention
Are you planning on attending #AIS2023?
Come and visit Mabqi during the 11th Antibody Industrial Symposium - June 22-23, 2023 in Tours (France).Get all the information and register at https://aiscongress.com/
New article about Mabqi
Follow Pierre Martineau, Director of Research at Inserm and have a look at Mabqi’s origin as creator of tailored antibodies. Know more about how started the company, what are its economic model and its ambitions for 2023. Read the article